ES8604734A1 - Un procedimiento para la preparacion de derivados de -lactama. - Google Patents

Un procedimiento para la preparacion de derivados de -lactama.

Info

Publication number
ES8604734A1
ES8604734A1 ES520214A ES520214A ES8604734A1 ES 8604734 A1 ES8604734 A1 ES 8604734A1 ES 520214 A ES520214 A ES 520214A ES 520214 A ES520214 A ES 520214A ES 8604734 A1 ES8604734 A1 ES 8604734A1
Authority
ES
Spain
Prior art keywords
lactams
compsns
cpds
esp
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES520214A
Other languages
English (en)
Other versions
ES520214A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES8604734A1 publication Critical patent/ES8604734A1/es
Publication of ES520214A0 publication Critical patent/ES520214A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE B-LACTAMA, DE FORMULA GENERAL (I), EN LA QUE R1 ES CO2-, CO2H O CO2R5, SIENDO R5 UN GRUPO TAL QUE EL AGRUPAMIENTO CO2R5 SEA UN ESTER HIDROLIZABLE IN VIVO FARMACEUTICAMENTE ACEPTABLE; Y R2 Y R3 REPRESENTAN INDEPENDIENTEMENTE UNGRUPO HIDROCARBONADO C1-12 OPCIONALMENTE SUSTITUIDO CON UN SUSTITUYENTE FUNCIONAL. CONSISTE EN LA HIDROGENACION DE UN COMPUESTO DE FORMULA (II), EN LA QUE R6 ES CO2-, CO2H O CO2RX, SIENDO RX UN GRUPO BLOQUEANTE DEL CARBOXI; Z ES UN ION CARGADO NEGATIVAMENTE; N ES 0 O 1 DE MODO QUE EL COMPUESTO DE FORMULA (II) SEA ELECTRONICAMENTE NEUTRO; Y R7 ES UN GRUPO R4 HIDROGENIZABLE. DE APLICACION EN EL TRATAMIENTO DE INFECCIONES EN ANIMALES, ESPECIALMENTE MAMIFEROS INCLUYENDO AL HOMBRE.
ES520214A 1981-03-10 1983-03-01 Un procedimiento para la preparacion de derivados de -lactama. Granted ES520214A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8107504 1981-03-10

Publications (2)

Publication Number Publication Date
ES8604734A1 true ES8604734A1 (es) 1984-04-01
ES520214A0 ES520214A0 (es) 1984-04-01

Family

ID=10520283

Family Applications (2)

Application Number Title Priority Date Filing Date
ES510266A Expired ES8403452A1 (es) 1981-03-10 1982-03-09 Un procedimiento para la preparacion de b-lactama.
ES520214A Granted ES520214A0 (es) 1981-03-10 1983-03-01 Un procedimiento para la preparacion de derivados de -lactama.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES510266A Expired ES8403452A1 (es) 1981-03-10 1982-03-09 Un procedimiento para la preparacion de b-lactama.

Country Status (5)

Country Link
EP (1) EP0062407A1 (es)
JP (1) JPS57167988A (es)
AU (1) AU8121982A (es)
ES (2) ES8403452A1 (es)
ZA (1) ZA821511B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU503489B2 (en) * 1975-10-13 1979-09-06 Beecham Group Limited Substituted aminodeoxy clavulanic acid
NL7612937A (nl) * 1975-11-21 1977-05-24 Merck & Co Inc Thienamycinederivaten en farmaceutische prepa- raten alsmede werkwijze voor het bereiden daarvan.
GB1604822A (en) * 1977-04-22 1981-12-16 Beecham Group Ltd N-monosubstituted-9-amino-9-deoxyclavulanic acid derivative

Also Published As

Publication number Publication date
EP0062407A1 (en) 1982-10-13
ZA821511B (en) 1983-01-26
JPS57167988A (en) 1982-10-16
AU8121982A (en) 1982-09-23
ES520214A0 (es) 1984-04-01
ES510266A0 (es) 1983-08-01
ES8403452A1 (es) 1983-08-01

Similar Documents

Publication Publication Date Title
IT8267464A0 (it) Composti cefalosporinici particolarmente per la cura delle affezioni da batteri gram positivi e gramnegativi composizioni farmaceutiche che li contengono e procedimento per la loro fabbricazione
FI962249A0 (fi) Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten
RU94030236A (ru) Производные 3 бета-алкенил-пенама, способ их получения, лекарственные средства и их применение для борьбы и предупреждения болезней
GR3019760T3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
SE9300758L (sv) Förfarande för framställning av kavulansyrasalter
IT7947650A0 (it) Penicilline e cefalosporine loro preparazione e loro impiego quali agenti antibatterici(caso 900-9210)
ES8604734A1 (es) Un procedimiento para la preparacion de derivados de -lactama.
FI844598A7 (fi) Hyaluronihapon valmistus mikrobiologisesta lähteestä ja sen käyttö eläinten nivelhäiriöiden hoitoon.
DE3476663D1 (en) Crystalline form of ceftazidim
ES8403968A1 (es) Procedimiento para obtener compuestos antibioticos que contienen fosforo.
NO934655L (no) Legemiddel for gram-positive sykdommer i akvatiske arter
BG42676A3 (en) Method for preparang derivatives of 6- aminoalkyl- penicillanic acid
IL82767A (en) Synergistic formulation comprising a cephem and a penem derivative for the treatment of bacterial infections
SE7712645L (sv) Monocykliska beta-laktamer med antibakteriell aktivitet
ES8205809A1 (es) Un procedimiento para la preparacion de derivados de metoxi-cefalosporinas
FR2336130A1 (fr) Composes utilisables dans le traitement des infections bacteriennes
FR2157811A1 (en) (6-substd) imidazo (2,1-b) thiazole compsns - plant antibacterial agents
SE7902669L (sv) Antibakteriell komposition
ES8102574A1 (es) Un procedimiento para la preparacion de naftalen-2-sulfonatode ester ftalidilico de ampicilina
IT1096593B (it) Derivati di cefalosporina e relativo procedimento di preparazione
PH24103A (en) Cephalosporin derivatives
ES8101076A1 (es) Un procedimiento para la preparacion del acido d-alfa-amino-alfa-(3,4-dihidroxifenil) acetamidopenicilanico.
ES8403135A1 (es) Un procedimiento para la preparacion de acido 6,-metoxi-6, -2-2-metilfenoxicarbonil-2-(tien-3-il) acetamido penicilanico.
NL7800658A (en) Antibacterial clavulanic acid amine salts - form synergistic compsn. with beta:lactam antibiotics, used e.g. in treating mastitis
IT1036078B (it) Composizione antibatterica per anima i